Xiangxue Pharmaceutical Subsidiary to Introduce Strategic Investor: Huagai Medical Invests RMB 100 Million in Xiangxue Life Sciences
Mar 07, 2021 16:28
CST Updated
16:28
Xiangxue
Developer, Producer, and Seller of Traditional Chinese Medicine and Chinese Herbal Pieces
Original Title:Xiangxue Pharmaceutical: Subsidiary Plans to Introduce Strategic Investors; Huagai Healthcare Invests RMB 100 Million in Xiangxue Life Sciences Source: Cailianshe
Xiangxue Pharmaceutical Announces Introduction of Strategic Investor Huagai Medical into Subsidiary Xiangxue Life Sciences; Huagai Medical to Inject RMB 100 Million Based on Pre-money Valuation of RMB 840 Million